Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 31  •  04:00PM ET
11.11
Dollar change
-0.03
Percentage change
-0.27
%
IndexRUT P/E- EPS (ttm)-10.06 Insider Own3.50% Shs Outstand46.31M Perf Week-5.77%
Market Cap515.53M Forward P/E12.34 EPS next Y0.90 Insider Trans3.84% Shs Float44.78M Perf Month-1.94%
Enterprise Value562.53M PEG- EPS next Q0.12 Inst Own91.26% Short Float5.18% Perf Quarter-1.24%
Income-463.20M P/S0.74 EPS this Y-40.74% Inst Trans-1.76% Short Ratio3.68 Perf Half Y-9.60%
Sales692.50M P/B0.66 EPS next Y12.50% ROA-34.21% Short Interest2.32M Perf YTD-30.21%
Book/sh16.76 P/C5.71 EPS next 5Y- ROE-46.17% 52W High21.12 -47.40% Perf Year-50.91%
Cash/sh1.95 P/FCF5.86 EPS past 3/5Y- -54.63% ROIC-51.82% 52W Low9.30 19.42% Perf 3Y-48.90%
Dividend Est.- EV/EBITDA6.53 Sales past 3/5Y-2.61% -0.28% Gross Margin54.02% Volatility3.72% 3.49% Perf 5Y-70.09%
Dividend TTM- EV/Sales0.81 EPS Y/Y TTM-6091.13% Oper. Margin6.32% ATR (14)0.40 Perf 10Y-60.95%
Dividend Ex-Date- Quick Ratio1.58 Sales Y/Y TTM1.48% Profit Margin-66.89% RSI (14)41.08 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio2.64 EPS Q/Q-4331.63% SMA20-2.55% Beta1.19 Target Price14.00
Payout- Debt/Eq0.18 Sales Q/Q1.92% SMA50-5.38% Rel Volume0.76 Prev Close11.14
Employees2227 LT Debt/Eq0.15 EarningsNov 05 BMO SMA200-14.14% Avg Volume630.31K Price11.11
IPOOct 21, 2014 Option/ShortYes / Yes EPS/Sales Surpr.13.33% 5.74% Trades Volume478,110 Change-0.27%
Date Action Analyst Rating Change Price Target Change
Jul-25-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
May-22-23Initiated CL King Buy $31
Aug-04-21Downgrade Stephens Overweight → Equal-Weight $60 → $45
Apr-13-20Upgrade Barclays Underweight → Equal Weight $30
Nov-07-19Downgrade Stifel Buy → Hold $45 → $35
Nov-06-19Downgrade Raymond James Outperform → Mkt Perform
Oct-16-18Initiated Barclays Equal Weight $69
Aug-21-18Upgrade Raymond James Mkt Perform → Outperform
Oct-27-25 10:31AM
Oct-23-25 08:00AM
Sep-18-25 08:42AM
Sep-15-25 07:00AM
Sep-10-25 12:35PM
01:08PM Loading…
Aug-06-25 01:08PM
Aug-05-25 07:45AM
06:45AM
06:41AM
06:30AM
Jul-31-25 04:15PM
Jul-24-25 10:20AM
Jul-16-25 09:39AM
Jul-15-25 05:25AM
Jun-09-25 07:15AM
09:16AM Loading…
May-13-25 09:16AM
May-09-25 06:51AM
May-07-25 12:50PM
03:12AM
12:33AM
May-06-25 09:47AM
08:25AM
07:25AM
07:00AM
Apr-28-25 07:47AM
Apr-25-25 04:49AM
Apr-17-25 12:24PM
Apr-03-25 07:54AM
Apr-02-25 07:00AM
Mar-28-25 11:30AM
05:29AM Loading…
Mar-24-25 05:29AM
Mar-17-25 07:30AM
Mar-11-25 10:26AM
Feb-27-25 03:02AM
02:13AM
Feb-26-25 08:25AM
07:33AM
07:00AM
Feb-19-25 08:54AM
Jan-28-25 09:12AM
Jan-27-25 10:07AM
Jan-06-25 08:54AM
Nov-12-24 12:07PM
Nov-11-24 09:38AM
Nov-08-24 04:16PM
Nov-05-24 07:00AM
Oct-31-24 09:40AM
03:11AM
03:10AM
Oct-30-24 08:00AM
07:00AM
06:45AM
Oct-23-24 06:19AM
Oct-17-24 12:00PM
Oct-09-24 03:32PM
09:40AM
Oct-02-24 08:36AM
Sep-19-24 09:40AM
Sep-13-24 09:50AM
Sep-09-24 10:54AM
10:29AM
Aug-22-24 09:40AM
Aug-12-24 10:36AM
Aug-05-24 09:40AM
Aug-01-24 12:55PM
Jul-31-24 08:20AM
07:16AM
07:00AM
Jul-26-24 12:43PM
Jul-24-24 06:14PM
Jul-01-24 07:00AM
May-13-24 07:15AM
May-06-24 10:54AM
May-03-24 01:14PM
04:21AM
03:31AM
May-02-24 11:56AM
08:47AM
08:25AM
07:24AM
07:00AM
Apr-25-24 11:16AM
Apr-02-24 11:18AM
Feb-21-24 07:18PM
09:37AM
08:59AM
Feb-20-24 07:36AM
07:34AM
07:00AM
Feb-13-24 08:41PM
Jan-05-24 10:15AM
Jan-04-24 08:00AM
Jan-02-24 10:53AM
Dec-01-23 11:31AM
Nov-07-23 01:08PM
Nov-05-23 12:33PM
Nov-02-23 12:25PM
Nov-01-23 10:21PM
09:14AM
07:42AM
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BLACKFORD GARYDirectorAug 13 '25Buy10.9940,000439,80040,000Aug 15 12:02 PM
BLACKFORD GARYDirectorAug 13 '25Buy10.9720,000219,50091,593Aug 15 12:02 PM
Holbrook KerrSVP, Chief Commercial OfficerMar 06 '25Sale15.257,000106,77882,047Mar 10 11:50 AM
Holbrook KerrOfficerMar 06 '25Proposed Sale15.257,000106,780Mar 06 05:05 PM
James MojiradeSVP, General CounselMar 04 '25Option Exercise0.008,039078,352Mar 06 02:25 PM
Woody Joseph FralinFormer Chief Executive OfficerMar 04 '25Option Exercise0.0032,1580453,203Mar 06 02:25 PM
Holbrook KerrSVP, Chief Commercial OfficerMar 04 '25Option Exercise0.005,145092,393Mar 06 02:24 PM
Hurley John JosephPrincipal Accounting OfficerMar 04 '25Option Exercise0.00107010,172Mar 06 02:23 PM
Greiner MichaelInterim CEOMar 04 '25Option Exercise0.0012,1490214,235Mar 06 02:22 PM